US03843E1047
US03843E1047
Aquestive Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 44.545.000 | 57.561.000 | 22.6% |
| Cost of Revenue | 18.555.000 | 17.872.000 | 3.8% |
| Gross Profit | 25.990.000 | 39.689.000 | 34.5% |
| 97.041.000 | 70.460.000 | 37.7% | |
| Operating Income | -71.051.000 | -30.771.000 | 130.9% |
| Pretax Income | -83.784.000 | -44.151.000 | 89.8% |
| Net Income Common Stockholders | -83.784.000 | -44.137.000 | 89.8% |
| -- | -- | -- | |
| -- | -- | -- |